How much funding has THERAPYX, INC. raised?

THERAPYX, INC. has raised $5.8M in total funding, most recently a Grant round.

Who are THERAPYX, INC.'s investors?

THERAPYX, INC.'s investors include National Institutes of Health.

When was THERAPYX, INC. founded?

THERAPYX, INC. was founded in 2015.

Where is THERAPYX, INC. headquartered?

THERAPYX, INC. is headquartered in BUFFALO, New York, United States.

What industry is THERAPYX, INC. in?

THERAPYX, INC. operates in Biotech, Healthcare.

How many employees does THERAPYX, INC. have?

THERAPYX, INC. has 1-10 employees.

THERAPYX, INC.

BUFFALO, United States · Founded 2015 · $5.8M raised

Biotech

Healthcare

Headquarters: BUFFALO, New York
Employees: 1–10
Founded: 2015
Business Model: B2G

Total Funding: $5.8M
Last Round: $3.0M GrantAug 2020
Rounds: 2

About

THERAPYX, INC. is an early-stage biotechnology company focused on nanoparticle-based oral drug delivery systems for metabolic diseases. The company has received multiple SBIR/STTR awards from the NIH/HHS for research including nanoencapsulated GLP-1 formulations for the treatment of Type 2 diabetes. It operates as a small R&D entity based in Madison, Wisconsin.

Summary

THERAPYX, INC. is a Biotech company based in BUFFALO, United States, founded in 2015. It has raised $5.8M in total across 2 rounds, most recently a $3.0M Grant round in Aug 2020. Investors include National Institutes of Health.